Gyre Therapeutics Inc (GYRE)

EBITDA Margin

-44.50%

Quarterly · Period ending:

GYRE logo

GYRE EBITDA Margin

Latest reported-44.50%
GYRE Quarterly EBITDA Margin (-2459.49% → -44.50%)
High-resolution chart · PNG

GYRE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-44.4975%
-38.0345%
1.6911%
27.0842%
-4.14%
23.4382%
4.0686%
17.1649%
24.8682%
47.4606%
-17.9792%
35.5471%
21.044%
26.3006%
-4.8228%
-3.9795%
0%
-1,837.2796%
-827.7869%
-1,094.0844%
-1,756.4488%
-1,526.4485%
-928.7051%
-1,798.2083%
-1,038.7214%
-24.612%
0%
0%
0%
0%
194,083.3333%
0%
0%
-110,766.6667%
-1,820.1258%
-1,835.5346%
-5,316.2162%
-1,521.4022%
-5,195.7746%
-4,277.9817%
-4,328.4404%
-4,098.1651%
-4,200.9174%
-3,075.2294%
-249.5925%
-443.3878%
-272.9129%
-5,960%
-5,947.2222%
-13,228.7356%
-14,309.6774%
0%
0%
-221.1538%
-2,874.4068%
-951.6927%
56.0499%
8.6888%
-48.2766%
-49.2271%
-12.3945%
31.5484%
-1.9408%
15.1757%
22.1893%
39.0511%
-756.1552%
6.0807%
-322.9329%
-68.3928%
-390.0744%
86.6659%
88.5165%
72.2188%
-793,240.3294%
-237.2942%
-319.1662%
-264.642%
-115,280.2345%
-566.1361%
-901,761.0921%
-1,330.6319%
-2,754.232%
-2,060.4032%
-2,714.5649%
-2,459.4859%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.